Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02350114 · ClinicalTrials.gov registry record · NA
An Observational Study of the Functional Capacity of Heart Failure
A NA study of Acute Heart Failure, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 6
- Study locations
NCT02350114: Completed NA study of Acute Heart Failure, sponsored by Bristol-Myers Squibb.
NCT02350114 is a NA study of Acute Heart Failure that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 51 participants, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02350114, a NA study of Acute Heart Failure, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.
Primary Outcome
The 6-minute walk test (6MWT) will be primary measure of functional capacity in these patients.
Conditions Studied
Interventions
- PROCEDURE 6 Minute Walk Test
Study Locations (6)
Michigan
- Cardioxyl Study Site - Detroit
- Cardioxyl Study Site - Detroit
Indiana
- Cardioxyl Study Site - Indianapolis
North Carolina
- Cardioxyl Study Site - Winston-Salem
Ohio
- Cardioxyl Study Site - Cincinnati
Tennessee
- Cardioxyl Study Site - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT02350114 record still lists
NCT02350114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which 6 Minute Walk Test is the first listed.
NCT02350114 lists 6 locations in 5 states (Michigan, Indiana, North Carolina).
Frequently Asked Questions
What is clinical trial NCT02350114 about?
NCT02350114 is a clinical study titled "An Observational Study of the Functional Capacity of Heart Failure". This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.
What is the current status of trial NCT02350114?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2014-11. Estimated completion is 2015-07.
What conditions does trial NCT02350114 study?
This clinical trial studies the following conditions: Acute Heart Failure.
What interventions are being tested in trial NCT02350114?
The interventions under investigation include: 6 Minute Walk Test (PROCEDURE).
Who is sponsoring clinical trial NCT02350114?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02350114 being conducted?
This trial has 6 study locations across Indiana, Michigan, North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02350114's enrollment target sits among peer trials
51 8th of 8 higher than 1 of 8 other Acute Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
COMPLETED · NA
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
COMPLETED · Phase 1
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia